Prepared by Dr. David Miller, CFA, Director of US Markets | Reviewed by Anna Kowalski, Lead Editor | Report ID: IGEMINI-41F744E3-20260531 | Data as of 2026-05-31
Executive Summary: carolyn aronson net worth operates in the Healthcare industry with a market cap of $2.19B. The stock trades at 58.34x earnings and exhibits 23.2% top-line growth. Our derived fair value is $2290.8.
Rating: Accumulate | Target Price: $2290.8 | Next Earnings: Jun 10
Download Full PDF Report
MACD printed a Bullish Crossover as the 50-day SMA turned positive 21 days ago.
Price action carved a Double Bottom, confirmed by a 0.75x volume spike on May 27, 2026. The resistance at $1826 was tested.
Free cash flow conversion remains robust at 82%, supporting the 0.7% dividend and buybacks.
EPS of $28.45 reveals high earnings quality. DuPont analysis highlights operating leverage as the key ROE driver.
Relative to Healthcare peers, carolyn aronson net worth sits at the 77th percentile in valuation, offering a potential value opportunity.
Short float at 5.6% is below the sector average, reducing squeeze risk. Institutional ownership is 85%.
Options skew is toward put at the 1826 strike, positioning for a directional move.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $1660 | $1577 |
| Market Cap | $2.19B | $2.63B |
| P/E Ratio | 58.34x | 49.6x |
| EPS (TTM) | $28.45 | $25.61 |
| Dividend Yield | 0.7% | 0.5% |
| Revenue Growth | 23.2% | 13.9% |
| Target Price | $2290.8 | - |
| Beta | 1.12 | 1.00 |